I prescribe Xanax rarely, and when I do I usually regret it within six months.

Perseris is monthly subcutaneous risperidone for schizophrenia. It can help when risperidone works but daily pills keep falling apart.

Risperdal Consta is older long-acting risperidone technology. It can help with adherence, but the two-week overlap and side effects matter.

Invega Sustenna is a long-acting injectable built for adherence, relapse prevention, and patients who do better without daily pill logistics.

Aristada is long-acting aripiprazole. The point isn't a new effect so much as steadier delivery and fewer missed-dose failures.

Abilify Maintena turns oral aripiprazole into a monthly adherence tool. The question is whether that solves the real problem.

Armodafinil is one of those drugs that lives in two different stories at once. In the boring real clinical story, it’s a wakefulness medication for excessive sleepiness in narcolepsy, shift work disorder, and residual sleepiness in obstructive sleep apnea when…

Azstarys is a two-speed dexmethylphenidate stimulant: one part starts fast, while the prodrug portion stretches the day.

Evekeo is plain amphetamine sulfate. It's older stimulant chemistry without the complicated release systems or marketing language.

Jornay PM is an unusual ADHD stimulant because it's taken at night so it can start helping the next morning.

Daytrana is a methylphenidate patch for ADHD when the problem is pill swallowing, school dosing, or needing more control over the day.